CYSTO-CONRAY II Drug Patent Profile
Which patents cover Cysto-conray Ii, and what generic alternatives are available?
Cysto-conray Ii is a drug marketed by Liebel-flarsheim and is included in one NDA.
The generic ingredient in CYSTO-CONRAY II is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYSTO-CONRAY II?
- What are the global sales for CYSTO-CONRAY II?
- What is Average Wholesale Price for CYSTO-CONRAY II?
Summary for CYSTO-CONRAY II
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 19 |
| Patent Applications: | 498 |
| Drug Prices: | Drug price information for CYSTO-CONRAY II |
| What excipients (inactive ingredients) are in CYSTO-CONRAY II? | CYSTO-CONRAY II excipients list |
| DailyMed Link: | CYSTO-CONRAY II at DailyMed |
Pharmacology for CYSTO-CONRAY II
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for CYSTO-CONRAY II
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liebel-flarsheim | CYSTO-CONRAY II | iothalamate meglumine | SOLUTION;INTRAVESICAL | 017057-002 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
